Skip to content

Clinical trials

Osteochondrodysplasias trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteochondrodysplasias Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20161
20171
20181
20191
20202
20212
20231
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Enrolling by invitation3
Recruiting3
Active, not recruiting2
No longer available1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company8
BioMarin Pharmaceutical5
Children's Hospitals and Clinics of Minnesota1
Christopher Dvorak1
Pfizer1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteochondrodysplasias17
Bone Diseases15
Musculoskeletal Diseases15
Genetic Diseases, Inborn14
Dwarfism12
Achondroplasia10
Mucopolysaccharidosis IV10
Bone Diseases, Developmental6
Bone Marrow Diseases1
Bone Marrow Failure Disorders1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.